Cognios Beta Neutral Large Cap Fund’s AbbVie ABBV Stock Holding History

Cognios Beta Neutral Large Cap Fund’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$548K	Sell	3,011 -731	-20%	-$126K	0.71%	40
2023 Q4	$580K	Sell	3,742 -193	-5%	-$28.1K	0.76%	42
2023 Q3	$587K	Sell	3,935 -733	-16%	-$108K	0.76%	51
2023 Q2	$629K	Sell	4,668 -2,032	-30%	-$298K	0.73%	70
2023 Q1	$1.06M	Sell	6,700 -299	-4%	-$45.7K	1.01%	24
2022 Q4	$1.13M	Buy	+6,999	New	+$1.07M	1.09%	19
2018 Q2	$219K	Buy	+2,373	New	+$232K	0.08%	147

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cognios Beta Neutral Large Cap Fund's ABBV Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its AbbVie (ABBV) stake by 20% in Q1 2024, selling an estimated $126K and leaving 3,011 shares worth $548K. The position accounts for 0.71% of the portfolio, ranked #40.

Cognios Beta Neutral Large Cap Fund first reported a position in ABBV in Q2 2018 and has held it in 7 quarters since. The position peaked at $1.13M in Q4 2022. 3,380 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

Cognios Beta Neutral Large Cap Fund held 3,011 shares of AbbVie worth $548K as of Q1 2024.
Cognios Beta Neutral Large Cap Fund sold 731 AbbVie shares in Q1 2024, an estimated $126K.
AbbVie made up 0.71% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #40 holding.
Cognios Beta Neutral Large Cap Fund first reported a position in AbbVie in Q2 2018 and has held it in 7 quarters since.
Cognios Beta Neutral Large Cap Fund's AbbVie position peaked at $1.13M in Q4 2022.
3,380 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.